ABUS logo

ABUS
Arbutus Biopharma Corp

16,783
Mkt Cap
$827.15M
Volume
8M
52W High
$5.10
52W Low
$2.94
PE Ratio
-23.95
ABUS Fundamentals
Price
$4.20
Prev Close
$4.25
Open
$4.24
50D MA
$4.43
Beta
0.94
Avg. Volume
3.1M
EPS (Annual)
-$0.1748
P/B
10.56
Rev/Employee
$741,210.53
$834.31
Loading...
Loading...
News
all
press releases
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures up, QuidelOrtho shares down in pre-market trading. Allbirds, MIND, Arbutus Biopharma among other stocks also falling.read more...
Benzinga·9d ago
News Placeholder
More News
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase - Here's Why
Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase - What's Next...
MarketBeat·10d ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200-Day Moving Average - What's Next?
Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above 200 Day Moving Average - Time to Sell...
MarketBeat·16d ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Posts Earnings Results
Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) posted its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.05. The business had revenue of $1.05 million for the quarter, compared to...
MarketBeat·1mo ago
News Placeholder
Arbutus Biopharma (ABUS) Projected to Post Quarterly Earnings on Thursday
Arbutus Biopharma (NASDAQ:ABUS) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-arbutus-biopharma-co-stock...
MarketBeat·1mo ago
News Placeholder
Foursixthree Capital LP Has $8.99 Million Stake in Arbutus Biopharma Corporation $ABUS
Foursixthree Capital LP decreased its holdings in shares of Arbutus Biopharma Corporation (NASDAQ:ABUS - Free Report) by 22.6% during the 3rd quarter, according to the company in its most recent Form...
MarketBeat·1mo ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Shares Down 8.4% - Time to Sell?
Arbutus Biopharma (NASDAQ:ABUS) Trading Down 8.4% - What's Next...
MarketBeat·1mo ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200 Day Moving Average - Here's Why
Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Moderna-Arbutus-Genevant Patent Settlement: Wall Street Says Not Best-Case Scenario But Removes Overhang For MRNA Stock
The news is likely to come as a relief to many investors, Citi told investors in a research note.
Stocktwits·2mo ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Sees Strong Trading Volume - What's Next?
Arbutus Biopharma (NASDAQ:ABUS) Sees Unusually-High Trading Volume - Still a Buy...
MarketBeat·2mo ago
<
1
2
...
>

Latest ABUS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.